The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Methamphetamine Use and Cardiovascular Disease: In Search of Answers
Open accessAbstract
While the opioid epidemic has garnered significant attention, the use of methamphetamines is growing worldwide independent of wealth or region. Following overdose and accidents, the leading cause of death in methamphetamine users is cardiovascular disease, because of significant effects of methamphetamine on vasoconstriction, pulmonary hypertension, atherosclerotic plaque formation, cardiac arrhythmias, and cardiomyopathy. In this review, we examine the current literature on methamphetamine-induced changes in cardiovascular health, discuss the potential mechanisms regulating these varied effects, and highlight our deficiencies in understanding how to treat methamphetamine-associated cardiovascular dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vital signs: changes in opioid prescribing in the United States, 2006-2015.
Guy, G. P., Zhang, K., Bohm, M. K., Losby, J., Lewis, B., Young, R., Murphy, L. B., & Dowell, D. (2017) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6626a4 · Cited by 1,117
Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis
Hansson, G. K., Libby, P., Schönbeck, U., & Yan, Z.-Q. (2002) · Circulation Research · doi:10.1161/01.res.0000029784.15893.10 · Cited by 1,024
New Insights into the Mechanism of Action of Amphetamines
Fleckenstein, A. E., Volz, T. J., Riddle, E. L., Gibb, J. W., & Hanson, G. R. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105140 · Cited by 731
U’PRICHARD, D. C., GREENBERG, D. A., & SNYDER, S. H. (1977) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)11222-4 · Cited by 550
Methamphetamine use: A comprehensive review of molecular, preclinical and clinical findings
Panenka, W. J., Procyshyn, R. M., Lecomte, T., MacEwan, G. W., Flynn, S. W., Honer, W. G., & Barr, A. M. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.11.016 · Cited by 432
Han, D. D., & Gu, H. H. (2006) · BMC Pharmacology · doi:10.1186/1471-2210-6-6 · Cited by 419
Implications of Chronic Methamphetamine Use: A Literature Review
Meredith, C. W., Jaffe, C., Ang-Lee, K., & Saxon, A. J. (2005) · Harvard Review of Psychiatry · doi:10.1080/10673220591003605 · Cited by 393
Homer, B. D., Solomon, T. M., Moeller, R. W., Mascia, A., DeRaleau, L., & Halkitis, P. N. (2008) · Psychological Bulletin · doi:10.1037/0033-2909.134.2.301 · Cited by 304
The prescription drug epidemic in the United States: A perfect storm
MAXWELL, J. C. (2011) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2011.00291.x · Cited by 275
Methamphetamine-Related Deaths in San Francisco: Demographic, Pathologic, and Toxicologic Profiles
Karch, S., Stephens, B., & Ho, C.-H. (1999) · Journal of Forensic Sciences · doi:10.1520/jfs14464j · Cited by 248
McKetin, R., Lubman, D. I., Baker, A. L., Dawe, S., & Ali, R. L. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.283 · Cited by 221
Cause and Manner of Death in Fatalities Involving Methamphetamine
Logan, B., Fligner, C., & Haddix, T. (1998) · Journal of Forensic Sciences · doi:10.1520/jfs16085j · Cited by 215
Ramirez, S. H., Potula, R., Fan, S., Eidem, T., Papugani, A., Reichenbach, N., Dykstra, H., Weksler, B. B., Romero, I. A., Couraud, P. O., et al. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.112 · Cited by 208
Robertson, S. D., Matthies, H. J. G., & Galli, A. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8053-4 · Cited by 205
Is Methamphetamine Use Associated With Idiopathic Pulmonary Arterial Hypertension?
Chin, K. M., Channick, R. N., & Rubin, L. J. (2006) · Chest · doi:10.1378/chest.130.6.1657 · Cited by 193
Schürer, S. C., Klingel, K., Sandri, M., Majunke, N., Besler, C., Kandolf, R., Lurz, P. C., Luck, M., Hertel, P., Schuler, G. C., et al. (2017) · JACC Heart Failure · doi:10.1016/j.jchf.2017.02.017 · Cited by 175
Wearne, T. A., & Cornish, J. L. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00491 · Cited by 173
Distribution and Pharmacokinetics of Methamphetamine in the Human Body: Clinical Implications
Volkow, N. D., Fowler, J. S., Wang, G.-J., Shumay, E., Telang, F., Thanos, P. K., & Alexoff, D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015269 · Cited by 167
Neurologic Manifestations of Chronic Methamphetamine Abuse
Rusyniak, D. E. (2013) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2013.02.005 · Cited by 160
Nguyen, E. C., McCracken, K. A., Liu, Y., Pouw, B., & Matsumoto, R. R. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.04.016 · Cited by 146
Methamphetamine‐Associated Cardiomyopathy
Won, S., Hong, R., Shohet, R. V., Seto, T. B., & Parikh, N. I. (2013) · Clinical Cardiology · doi:10.1002/clc.22195 · Cited by 145
Crystal Methamphetamine‐Associated Cardiomyopathy: Tip of the Iceberg?
Wijetunga, M., Seto, T. B., Lindsay, J. M., & Schatz, I. J. (2003) · Journal of Toxicology Clinical Toxicology · doi:10.1081/clt-120026521 · Cited by 145
Methamphetamine blood concentrations in human abusers: Application to pharmacokinetic modeling
Melega, W. P., Cho, A. K., Harvey, D. C., & Laćan, G. (2007) · Synapse · doi:10.1002/syn.20365 · Cited by 138
Prescription drug abuse: from epidemiology to public policy
McHugh, R. K., Nielsen, S., & Weiss, R. D. (2014) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2014.08.004 · Cited by 132
Pulmonary Hypertension Associated With Long-term Inhalation of “Crank” Methamphetamine
Schaiberger, P. H., Kennedy, T. C., Miller, F. C., Gal, J., & Petty, T. L. (1993) · CHEST Journal · doi:10.1378/chest.104.2.614 · Cited by 130
The mechanism for the neuroprotective effect of melatonin against methamphetamine‐induced autophagy
Nopparat, C., Porter, J. E., Ebadi, M., & Govitrapong, P. (2010) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00805.x · Cited by 128
Kaye, S. S., Darke, S. G., Duflou, J. A., & McKetin, R. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02231.x · Cited by 128
Neurologic Manifestations of Chronic Methamphetamine Abuse
Rusyniak, D. E. (2011) · Neurologic Clinics · doi:10.1016/j.ncl.2011.05.004 · Cited by 126
Darke, S. G., Kaye, S. S., & Duflou, J. A. (2017) · Addiction · doi:10.1111/add.13897 · Cited by 125
Potula, R., Hawkins, B. J., Cenna, J. M., Fan, S., Dykstra, H., Ramirez, S. H., Morsey, B., Brodie, M. R., & Persidsky, Y. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903691 · Cited by 118
The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission
Sambo, D. O., Lin, M., Owens, A. W., Lebowitz, J. J., Richardson, B., Jagnarine, D. A., Shetty, M., Rodriquez, M., Alonge, T., Ali, M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02087-x · Cited by 115
Amphetamines promote mitochondrial dysfunction and DNA damage in pulmonary hypertension
Chen, P.-I., Cao, A., Miyagawa, K., Tojais, N. F., Hennigs, J. K., Li, C. G., Sweeney, N. M., Inglis, A. S., Wang, L., Li, D., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.90427 · Cited by 109
Methamphetamine induces AP‐1 and NF‐κB binding and transactivation in human brain endothelial cells
Lee, Y. W., Hennig, B., Yao, J. J., & Toborek, M. J. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1248 · Cited by 100
Prevalence and nature of cardiovascular disease in methamphetamine-related death: A national study
Darke, S. G., Duflou, J. A., & Kaye, S. S. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.07.001 · Cited by 100
Ma, J., Wan, J., Meng, J., Banerjee, S., Ramakrishnan, S., & Roy, S. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.64 · Cited by 99
Zhao, S. X., Kwong, C., Swaminathan, A., Gohil, A., & Crawford, M. H. (2018) · JACC Heart Failure · doi:10.1016/j.jchf.2017.10.006 · Cited by 90
Reese, E. A., Bunzow, J. R., Arttamangkul, S., Sonders, M. S., & Grandy, D. K. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.115402 · Cited by 88
Electrocardiographic abnormalities in methamphetamine abusers
Haning, W., & Goebert, D. A. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01776.x · Cited by 86
Overview of the Microenvironment of Vasculature in Vascular Tone Regulation
Loh, Y. C., Tan, C. S., Ch’ng, Y. S., Yeap, Z. Q., Ng, C. H., & Yam, M. F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010120 · Cited by 77
Cardiac Muscle Lesions Associated with Chronic Administration of Methamphetamine in Rats
He, S.-Y., Matoba, R., Fujitani, N., Sodesaki, K.-I., & Onishi, S. (1996) · American Journal of Forensic Medicine & Pathology · doi:10.1097/00000433-199606000-00014 · Cited by 63
Orcholski, M. E., Khurshudyan, A., Shamskhou, E. A., Yuan, K., Chen, I. Y., Kodani, S. D., Morisseau, C. H. P., Hammock, B. D., Hong, E. M., Alexandrova, L. А., et al. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00453.2016 · Cited by 63
Methamphetamine causes sustained depression in cerebral blood flow
Polesskaya, O., Silva, J., Sanfilippo, C. M., DesRosiers, T., Sun, A., Shen, J., Feng, C., Polesskiy, A., Deane, R., Zloković, B. V., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2010.12.017 · Cited by 57
Methamphetamine use and heart failure: Prevalence, risk factors, and predictors
Richards, J. R., Harms, B. N., Kelly, A., & Turnipseed, S. D. (2018) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2018.01.001 · Cited by 57
Fehler, M., Broadley, K. J., Ford, W. R., & Kidd, E. J. (2010) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-010-0554-1 · Cited by 52
Methamphetamine-induced vascular changes lead to striatal hypoxia and dopamine reduction
Kousik, S. M., Graves, S. M., Napier, T. C., Zhao, C., & Carvey, P. M. (2011) · Neuroreport · doi:10.1097/wnr.0b013e32834d0bc8 · Cited by 52
Broadley, K. J., Fehler, M., Ford, W. R., & Kidd, E. J. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.04.034 · Cited by 40
Vozenilek, A. E., Navratil, A. R., Green, J. M., Coleman, D. T., Blackburn, C. M. R., Finney, A. C., Pearson, B. H., Chrast, R., Finck, B. N., Klein, R. L., et al. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.310455 · Cited by 40
Self-citationMaeno, Y., Iwasa, M., Inoue, H., et al. (2000) · Forensic Science International · doi:10.1016/s0379-0738(00)00216-4 · Cited by 39
Acute methamphetamine exposure inhibits cardiac contractile function
Turdi, S., Schamber, R. M., Roe, N. D., Chew, H. G., Culver, B. W., & Ren, J. T. (2009) · Toxicology Letters · doi:10.1016/j.toxlet.2009.05.015 · Cited by 37
Gao, B., Li, L., Zhu, P., Zhang, M., Hou, L., Sun, Y., Liu, X., Peng, X., & Gu, Y. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.09.001 · Cited by 37
Methamphetamine induces the release of endothelin
Seo, J., Jones, S. M., Hostetter, T. A., Iliff, J. J., & West, G. A. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23697 · Cited by 35
Lewin, A. H., Miller, G. M., & Gilmour, B. P. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.10.007 · Cited by 31
Ben‐Yehuda, O., & Siecke, N. W. (2018) · JACC Heart Failure · doi:10.1016/j.jchf.2018.01.004 · Cited by 24
Effect of an Electronic Control Device Exposure on a Methamphetamine‐intoxicated Animal Model
Dawes, D. M., Ho, J. D., Cole, J. B., Reardon, R. F., Lundin, E. J., Terwey, K. S., Falvey, D., & Miner, J. R. (2010) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2010.00708.x · Cited by 21
Pujol‐López, M., Ortega‐Paz, L., Flores‐Umanzor, E., Perea, R. J., & Bosch, X. (2017) · JACC Heart Failure · doi:10.1016/j.jchf.2017.08.009 · Cited by 18
Fleury, G., Garza, R. D. L., Mahoney, J. J., Evans, S. E., & Newton, T. F. (2008) · American Journal on Addictions · doi:10.1080/10550490701861078 · Cited by 14
Zhu, P., Li, L., Gao, B., Zhang, M., Wang, Y., Gu, Y., & Liqun, H. (2017) · Oncotarget · doi:10.18632/oncotarget.19020 · Cited by 9
Cited by
OECD, & Fund, T. K. (2020) · OECD eBooks · doi:10.1787/47a04a11-en · Cited by 435
Neurobiology, Clinical Presentation, and Treatment of Methamphetamine Use Disorder: A Review
Paulus, M. P., & Stewart, J. L. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.0246 · Cited by 310
Shoptaw, S., Li, M. J., Javanbakht, M., Ragsdale, A., Goodman-Meza, D., & Gorbach, P. M. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109320 · Cited by 37
Prenatal methamphetamine—impact on the mother and child—a review
Perez, F. A., Blythe, S., Wouldes, T., McNamara, K., Black, K. I., & Oei, J. L. (2022) · Addiction · doi:10.1111/add.15509 · Cited by 31
Methamphetamine induces cardiomyopathy through GATA4/NF-κB/SASP axis-mediated cellular senescence
Zhao, X., Lu, J., Zhang, C., Chen, C., Zhang, M., Zhang, J., Du, Q., & Wang, H. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116457 · Cited by 12
Metadata
- Authors
- Kevil, C. G., Goeders, N. E., Woolard, M. D., Bhuiyan, M. S., Dominic, P., Kolluru, G. K., Arnold, C. L., Traylor, J. G., & Orr, A. W.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2019-09
- Volume
- 39
- Issue
- 9
- Pages
- 1739-1746
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2969628213
- Cited by
- 294
- References
- 57
- FWCI
- 17.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.